Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Amyloid PET imaging in multiple sclerosis: an (18)F-florbetaben study.
Solifenacin is effective and well tolerated in patients with neurogenic detrusor overactivity: Results from the double-blind, randomized, active- and placebo-controlled SONIC urodynamic study.
Changes in tissue directionality reflect differences in myelin content after demyelination in mice spinal cords.
In vivo quantitative whole-brain T1 rho MRI of multiple sclerosis.
miR-17-92 cluster targets Phosphatase and Tensin Homology and Ikaros Family Zinc Finger 4 to promote TH17-mediated inflammation.
Therapeutic satisfaction and subjective effects of different strains of pharmaceutical-grade cannabis.
Angiopoietin-1 ameliorates inflammation-induced vascular leakage and improves functional impairment in a rat model of acute experimental autoimmune encephalomyelitis.
Brain-specific knockdown of miR-29 results in neuronal cell death and ataxia in mice.
Multiple sclerosis: KIR4.1 as an autoantigen in MS-new questions raised.
Dynamics of sodium channel Nav1.5 expression in astrocytes in mouse models of multiple sclerosis.
Antibody response against gastrointestinal antigens in demyelinating diseases of the central nervous system.
Functional Homotopic Changes in Multiple Sclerosis with Resting-State Functional MR Imaging.
Glia Maturation Factor Induces Interleukin-33 Release from Astrocytes: Implications for Neurodegenerative Diseases.
Multiple sclerosis: Monotherapy rules.
TNFRSF1A polymorphisms and MS: Statistical signals transform into pathogenetic mechanisms.
Quantitative PCR for Epstein-Barr virus DNA and RNA in multiple sclerosis.
Aquaporins, anti-aquaporin-4 autoantibodies and neuromyelitis optica.
Cerebrospinal fluid aquaporin-4-immunoglobulin G disrupts blood brain barrier.
Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS Meeting (II).
Sodium Benzoate, a Metabolite of Cinnamon and a Food Additive, Upregulates Ciliary Neurotrophic Factor in Astrocytes and Oligodendrocytes.
Evaluation of Retinal Nerve Fiber Layer and Ganglion Cell Complex in Patients with Optic Neuritis or Neuromyelitis Optica Spectrum Disorders Using Optical Coherence Tomography in a Chinese Cohort.
Low-level laser therapy ameliorates disease progression in a mouse model of multiple sclerosis.
Association Between the Neurogenic Bladder Symptom Score and Urodynamic Examination in Multiple Sclerosis Patients With Lower Urinary Tract Dysfunction.
Advances in the management of MS symptoms: real-life evidence.
Endogenously regulated Dab2 worsens inflammatory injury in experimental autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
338
339
340
341
342
343
344
345
346
…
next ›
last »